1.4 years on finasteride, only lately have signs of improvement been showing
    Progress Pictures 2/18/2025

    From the encyclopedia
    Finasteride →

    Frontline, gold standard treatment for combatting androgenic alopecia

    Minoxidil →

    An essential vasodilator with some anti-androgenic effects

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    💊 Finasteride (oral) 1.4 years
    💧 Minoxidil (topical)
    the tone is 😀 positive with some growth results.

    Other terms

    The user noticed hair density improvement after 1.4 years on finasteride, with additional use of minoxidil on the temples. Other users discussed various treatments like dutasteride, estrogen, and hair transplants, sharing personal experiences and advice.
    View this post in the Community →

    Similar Community Posts Join

    5 / 5 results

    Related Research

    6 / 6 results
      Menopause and Hair Loss in Women: Exploring the Hormonal Transition

      research Menopause and hair loss in women: Exploring the hormonal transition

      1 citations , May 2025 in “Maturitas”
      This article highlights that hormonal changes during menopause can significantly affect hair health, leading to decreased hair density, altered texture, and increased hair disorders, which may subsequently impact emotional well-being in women.
      Androgens and Hair Loss: An In-Depth Analysis of Androgenetic Alopecia

      research Androgens and hair loss

      52 citations , June 2009 in “Current Opinion in Endocrinology, Diabetes and Obesity”
      This review discusses the pathogenesis and treatment of androgenetic alopecia, highlighting genome associations and newer topical formulations, but reports no new clinical results.
      Safety Concerns When Using Novel Medications to Treat Alopecia

      research Safety concerns when using novel medications to treat alopecia

      23 citations , October 2018 in “Expert Opinion on Drug Safety”
      This review discusses the safety concerns associated with new treatments for non-scarring alopecias, highlighting that while these therapies such as JAK inhibitors and oral minoxidil show efficacy in hair regrowth, their safety profiles vary significantly, requiring careful consideration of benefits and risks.